Target intelligence / Profile preview

Potassium channel, vascular smooth muscle

Molecular classification
Ion channel, Potassium channel, Voltage-gated ion channel, Calcium-activated potassium channel, ATP-sensitive potassium channel, Inward-rectifier potassium channel
01

Overview

Potassium channels in vascular smooth muscle are a group of ion channels responsible for the majority of potassium conductance in vascular smooth muscle cell membranes, critically regulating membrane potential and thereby modulating smooth muscle contraction, vascular tone, and cell proliferation. Five major classes—large-conductance Ca2+-activated (BK_Ca), intermediate-conductance Ca2+-activated (K_Ca3.1), voltage-gated (K_V), ATP-sensitive (K_ATP), and inward-rectifier (Kir)—combine in distinct patterns in different vessel types and regulate responses to vasoconstrictors and vasodilators. Dysregulation of these channels is implicated in hypertension, atherosclerosis, and other cardiovascular pathologies. They are established therapeutic targets for several vasodilators and antihypertensive drugs, but drug selectivity and safety remain ongoing challenges for clinical use[1][2][3][5].

Other names
Vascular smooth muscle potassium channelVSM potassium channel
02

Mechanism of action

Membrane hyperpolarization leading to vasodilation; Modulation of vascular smooth muscle excitability; Inhibition reduces hyperpolarization, leading to vasoconstriction; Drug-induced opening of K+ channels causes relaxation of vascular smooth muscle[5][3][2]

03

Biological functions

Regulation of membrane potentialControl of vascular toneVascular smooth muscle contraction and relaxationRegulation of cell proliferationSignal transduction
04

Disease associations

Cardiovascular diseaseHypertensionPulmonary hypertensionDiabetes mellitusAtherosclerosisOther vascular disorders
05

Safety considerations

Off-target cardiovascular effects (e.g., hypotension, arrhythmia)Disturbance of normal vascular toneInadequate selectivity among channel subtypes may cause systemic side effects[5][3]
06

Interacting drugs

Minoxidil (K_ATP channel opener)

4 more in the full profile.

07

Biomarkers

Channel subunit expression (e.g., Kv7.4, Kv7.5, BK_Ca, Kir) as potential prognostic/therapeutic markers in vascular disease states (experimental/limited clinical usage)[2][5]

Beyond the preview

Go deeper on Potassium channel, vascular smooth muscle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel, vascular smooth muscle.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call